With its evolving Cores, enrichment and training programs, and supported research projects, the San Antonio (SA) Nathan Shock Aging Center has for nearly 20 years provided critical support to investigators locally, nationally and abroad. With its existing and growing intellectual capital, the SA Shock Center is poised to provide (1) an enhanced platform to conduct horizontally-integrated (lifespan, healthspan, pathology) transformative research in the biology of aging, and (2) a springboard for advanced educational and training activities.
The Specific Aims of the SA Nathan Shock Center are: 1. To be a leader in research that advances our understanding of the biology of aging 2. To provide a 'one-stop-shop' venue to accelerate transformative research in the biology of aging 3. To foster and promote career development of early-stage investigators in aging biology 4. To serve as a resource and partner to investigators from other Shock Centers, institutions, and the public, for dissemination of scientific knowledge and enhancing awareness about aging research To achieve these objectives we have leveraged and streamlined our resources and strengths to create six interrelated cores: The: 1) Administration and Program Enrichment Core; 2) Research Development Core; 3) Aging Animal Models and Longevity Assessment Core; 4) Healthspan and Functional Assessment Core; 5) Pathology Core; and 6) the Bioanalytical Pharmacology and Drug Evaluation Core. These cores will provide an integrated venue to conduct and facilitate carefully phenotyped and well- integrated (i.e. lifespan, healthspan, pathology) aging studies. Using these cores, we will apply genetic, biochemical, and pharmacologic methodologies to several animal models including Caenorhabditis elegans, rodents (mice, rats, naked mole rats), and marmosets. Based on our past experiences and successes, we fully anticipate that our enhanced platform and training activities will greatly facilitate the identification of molecular and cellular mechanisms that influence aging. This approach we anticipate will result in novel strategies and the identification of (pharmacologic) targets to extend healthy life expectancy.

Public Health Relevance

The aging process plays an important role in the development of chronic disease and disability. The goal of the San Antonio Nathan Shock Center is to discover the molecular and cellular mechanisms that control the aging process, in order to develop strategies to promote healthy aging.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG013319-24
Application #
9521919
Study Section
Special Emphasis Panel (ZAG1)
Program Officer
Sierra, Felipe
Project Start
1997-07-15
Project End
2020-06-30
Budget Start
2018-07-15
Budget End
2019-06-30
Support Year
24
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Texas Health Science Center
Department
Pharmacology
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Weiss, Roxanne; Fernandez, Elizabeth; Liu, Yuhong et al. (2018) Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice. Aging (Albany NY) :
Qin, Kunhua; Zhang, Ning; Zhang, Zhao et al. (2018) SIRT6-mediated transcriptional suppression of Txnip is critical for pancreatic beta cell function and survival in mice. Diabetologia 61:906-918
Salmon, Adam B; Dorigatti, Jonathan; Huber, Hillary F et al. (2018) Maternal nutrient restriction in baboon programs later-life cellular growth and respiration of cultured skin fibroblasts: a potential model for the study of aging-programming interactions. Geroscience 40:269-278
Gelfond, Jonathan; Goros, Martin; Hernandez, Brian et al. (2018) A System for an Accountable Data Analysis Process in R. R J 10:6-21
Sills, Aubrey M; Artavia, Joselyn M; DeRosa, Brian D et al. (2018) Long-term treatment with the mTOR inhibitor rapamycin has minor effect on clinical laboratory markers in middle-aged marmosets. Am J Primatol :e22927
Xu, Ming; Pirtskhalava, Tamar; Farr, Joshua N et al. (2018) Senolytics improve physical function and increase lifespan in old age. Nat Med 24:1246-1256
Unnikrishnan, Archana; Hadad, Niran; Masser, Dustin R et al. (2018) Revisiting the genomic hypomethylation hypothesis of aging. Ann N Y Acad Sci 1418:69-79
Van Skike, Candice E; Jahrling, Jordan B; Olson, Angela B et al. (2018) Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment. Am J Physiol Heart Circ Physiol 314:H693-H703
Mao, Kai; Quipildor, Gabriela Farias; Tabrizian, Tahmineh et al. (2018) Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice. Nat Commun 9:2394
Lee, Hak Joo; Feliers, Denis; Barnes, Jeffrey L et al. (2018) Hydrogen sulfide ameliorates aging-associated changes in the kidney. Geroscience 40:163-176

Showing the most recent 10 out of 231 publications